| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |